NOVO NORDISK A/S |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 124.3 USD | -3.80% |
|
-1.03% | +20.35% |
| 09:59pm | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
| 09:15pm | News Highlights : Top Company News of the Day - Thursday at 3 PM ET | DJ |
ETFs positioned on Novo Nordisk A/S
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.75% | 9 M€ | -4.31% | - |
Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- diabetes and obesity treatment products (92.6%);
- rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc.
Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
Pharmaceuticals
Calendar
06:30am
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
897.7
DKK
Average target price
904.2
DKK
Spread / Average Target
+0.72%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +29.86% | 699B | |
| -4.80% | 364B | |
| +17.76% | 326B | |
| +3.48% | 286B | |
| +14.68% | 236B | |
| +4.71% | 198B | |
| -12.43% | 194B | |
| -3.66% | 154B | |
| -3.57% | 149B |
- Stock Market
- Equities
- NOVO B Stock
- NVO Stock
- Funds and ETFs Novo Nordisk A/S
